[EFFECT OF A SPIRONOLACTONE ALDOSTERONE INHIBITOR AND CHLOROTHIAZIDE ON WATER AND ELECTROLYTE EXCRETION IN LIVER DISEASES].
D000450:Aldosterone; D035843:Biomedical Research; D001826:Body Fluids; D002740:Chlorothiazide; D004573:Electrolytes; D008107:Liver Diseases; D000451:Mineralocorticoid Receptor Antagonists; D010600:Pharmacology; D013148:Spironolactone; D014556:Urine; D014867:Water; D014882:Water-Electrolyte Balance
D004573:Electrolytes; D000451:Mineralocorticoid Receptor Antagonists; D014867:Water; D013148:Spironolactone; D000450:Aldosterone; D002740:Chlorothiazide
ALDOSTERONE ANTAGONISTS; CHLOROTHIAZIDE; CLINICAL RESEARCH; LIVER DISEASES; PHARMACOLOGY; URINE; WATER-ELECTROLYTE BALANCE
DEJSTVO SPIRONOLAKTONSKOG INHIBITORA ALDOSTERONA I HLOROTIJAZIDA NA IZLU CIVANJE VODE I ELEKTROLITA U BOLESTIMA JETRE.